An injectable antibody-loaded supramolecular nanofiber hydrogel has been created by simply mixing betamethasone phosphate (BetP), a clinical anti-inflammatory drug, anti-VEGF, the gold-standard anti-VEGF drug for AMD treatment, with CaCl2. The gene discussed is VEGFA; the disease is age-related macular degeneration.